Carrageenan and agar
Also called: carrageenan, E 407, processed Eucheuma seaweed (E 407a), agar, agar-agar, E 406, kanten
Carrageenan and agar are polysaccharides extracted from red seaweeds and used as food additives. Carrageenan serves as an emulsifier, stabilizer or thickener; agar-agar as a stabilizer, thickener, flavoring agent or drying agent. Both are permitted in US and EU foods.
- Category
- Marine and algae
- Forms
- Carrageenan: refined hydrocolloid from Chondrus, Eucheuma and Gigartina species; agar: dried colloidal polysaccharide from red algae
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-28
Class 2 Moderately studied in people. This entry cites 8 RCTs of carrageenan or agar alone taken by mouth: carrageenan in sources 3, 4, 9 and 10 (7 to 20 participants); agar in sources 5 and 11-13 (10 to 160 participants). Source 13's abstract does not state randomization; MEDLINE indexes it as an RCT. [3]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CStomach and gut2 topics
CBlood sugar and weight1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Relapse of ulcerative colitis with carrageenan | C | RCT of 12 people with ulcerative colitis in remission on a no-carrageenan diet: 3 given carrageenan capsules relapsed versus none given placebo, within up to one year. [3] |
| Inflammation and gut symptoms in ulcerative colitis | C | Crossover pilot RCT in 7 people with quiescent ulcerative colitis: 7 days of food-grade carrageenan did not change disease activity or inflammatory markers versus placebo. [4] |
| Weight in obese adults with impaired glucose tolerance or type 2 diabetes (agar) | C | RCT in 76 patients: adding agar to a conventional diet for 12 weeks gave greater weight loss (−2.8 vs −1.3 kg) and total cholesterol reduction than diet alone. [5] |
Main constituents: Carrageenan: sulfated polysaccharide of galactose and anhydrogalactose units, 20% to 40% sulfate (dry weight) [1]; Agar-agar: dried, hydrophilic, colloidal polysaccharide [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Agar 4,500 mg per person per day (about 64 mg/kg body weight) was tolerated for 12 weeks without noticeable side effects. [6]
Upper limits
- EFSA (2018): group acceptable daily intake of 75 mg/kg body weight per day for carrageenan (E 407) and processed Eucheuma seaweed (E 407a), considered temporary pending better data. [7]
- EFSA (2016): no numerical ADI needed for agar (E 406). [6]
- US: agar-agar maximum use levels are 0.8% in baked goods, 2.0% in confections and frostings, 1.2% in soft candy and 0.25% in all other foods. [2]
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)2 found
Each names the exact material tested, which may differ from a supplement.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- EFSA: carrageenan is not absorbed intact; no concern for genotoxicity or carcinogenicity; no adverse effects in chronic rat studies up to 7,500 mg/kg body weight per day. Uncertainties remain in chemistry, exposure and toxicology data. [7]
- Poligeenan (average molecular weight 10–20 kDa) is not authorized as a food additive and is not used in foods. [7]
- EFSA: agar is unlikely to be absorbed unchanged, is slightly fermented by gut bacteria, and raises no safety concern at reported uses. [6]
Identity, quality and standardization
Regulatory status
- US: carrageenan is a permitted food additive (21 CFR 172.620) as an emulsifier, stabilizer or thickener; salts of carrageenan are covered by 21 CFR 172.626. [1]
- US: agar-agar is listed under 21 CFR 184.1115 (direct food substances affirmed as GRAS) as a drying agent, flavoring agent, stabilizer and thickener. [2]
- EU: carrageenan (E 407), processed Eucheuma seaweed (E 407a) and agar (E 406) are authorized food additives that EFSA re-evaluated in 2018 and 2016. [7]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming carrageenan or agar was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29); two entries name oligosaccharide ingredients ('Agaro-oligosaccharide', NDI 126, submitted 2001-10-18; 'neoagarooligosaccharides', NDI 1237, submitted 2021-11-24), not agar itself. FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P1]
- Carrageenan is a food additive permitted under 21 CFR 172.620, defined as the refined hydrocolloid prepared by aqueous extraction from listed red seaweeds of the families Gigartinaceae and Solieriaceae. [P4]
- 21 CFR 184.1115 lists agar-agar for use in food under stated maximum levels (for example 0.8% in baked goods and baking mixes, 2.0% in confections and frostings, 0.25% in all other food categories, as served). [P5]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- IARC: Carrageenan, native, Group 3 (not classifiable), Volume 31 and Supplement 7 (1987). Carrageenan, degraded (poligeenan), Group 2B (possibly carcinogenic to humans), Volume 31 and Supplement 7 (1987). These are two different materials. [P3]
- EFSA (2018) states that poligeenan (average molecular weight 10–20 kDa) has not been authorised as a food additive and is not used in any food applications, and found no concern with respect to the carcinogenicity of food-grade carrageenan (E 407). [P6]
- NTP TR-230 (March 1982): agar isolated from Pterocladia, fed at 25,000 or 50,000 ppm for 103 weeks, was not carcinogenic for F344 rats or B6C3F1 mice of either sex. No IARC classification of agar was found. [P8]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of the dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants a petition for an exemption under 111.75(a)(1)(ii). [P2]
- Sulfate content (carrageenan) — 21 CFR 172.620(b) specifies a sulfate content of 20 to 40 percent on a dry-weight basis for carrageenan. [P4]
- Food Chemicals Codex specifications (agar) — 21 CFR 184.1115(b) states agar-agar meets the specifications of the Food Chemicals Codex, 3d Ed. (1981). [P5]
Supply and conservation
- 21 CFR 172.620 names the source seaweeds for carrageenan: Chondrus crispus, Chondrus ocellatus, Eucheuma cottonii, Eucheuma spinosum, Gigartina acicularis, Gigartina pistillata, Gigartina radula and Gigartina stellata. [P4]
- 21 CFR 184.1115: agar-agar is extracted from one of a number of related species of red algae (class Rhodophyceae). [P5]
Absorption in people
- EFSA (2018): the ADME database was sufficient to conclude that carrageenan was not absorbed intact. [P6]
- EFSA (2016): agar is unlikely to be absorbed unchanged and is slightly fermented by intestinal microbiota; an oral intake of 4,500 mg/person (64 mg/kg bw per day) was tolerated in humans for 12 weeks without noticeable side effects. [P7]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- IARC Monographs. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- eCFR. 21 CFR 172.620 Carrageenan (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- eCFR. 21 CFR 184.1115 Agar-agar (up to date as of 10/15/2026), 2026-10-15. ecfr.gov
- EFSA ANS Panel. Re-evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives. EFSA J 2018;16(4):e05238 (PMID 32625873), 2018-04-26. pubmed.ncbi.nlm.nih.gov
- EFSA ANS Panel. Re-evaluation of agar (E 406) as a food additive. EFSA J 2016;14(12):e04645 (PMID 42006017), 2016-12-21. pubmed.ncbi.nlm.nih.gov
- National Toxicology Program. TR-230: Carcinogenesis Bioassay of Agar in F344 Rats and B6C3F1 Mice (Feed Study) (March 1982), 1982-03. ntp.niehs.nih.gov
Sources
- eCFR. 21 CFR 172.620 Carrageenan (current as of October 27, 2026), 2026-10-27. ecfr.gov
- eCFR. 21 CFR 184.1115 Agar-agar (current as of October 27, 2026), 2026-10-27. ecfr.gov
- Bhattacharyya S, et al. A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity. Nutr Healthy Aging 2017;4(2):181-192, 2017-03-31. pubmed.ncbi.nlm.nih.gov
- Laatikainen R, et al. Randomized controlled pilot study: effect of carrageenan emulsifier on inflammation and gastrointestinal symptoms in quiescent ulcerative colitis. Food Nutr Res 2023;67, 2023-10-30. pubmed.ncbi.nlm.nih.gov
- Maeda H, et al. Effects of agar (kanten) diet on obese patients with impaired glucose tolerance and type 2 diabetes. Diabetes Obes Metab 2005;7(1):40-6, 2005-01. pubmed.ncbi.nlm.nih.gov
- EFSA ANS Panel. Re-evaluation of agar (E 406) as a food additive. EFSA J 2016;14(12):e04645, 2016-12-21. pubmed.ncbi.nlm.nih.gov
- EFSA ANS Panel. Re-evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives. EFSA J 2018;16(4):e05238, 2018-04-26. pubmed.ncbi.nlm.nih.gov
- eCFR. 21 CFR 172.626 Salts of carrageenan (current as of October 27, 2026), 2026-10-27. ecfr.gov
- Wagner R, et al. Carrageenan and insulin resistance in humans: a randomised double-blind cross-over trial. BMC Med 2024;22(1):558 (PMID 39593091), 2024-11-26. pubmed.ncbi.nlm.nih.gov
- Panlasigui LN, et al. Blood cholesterol and lipid-lowering effects of carrageenan on human volunteers. Asia Pac J Clin Nutr 2003;12(2):209-14 (PMID 12810413), 2003. pubmed.ncbi.nlm.nih.gov
- Abdel-Aziz Ali SM, et al. Efficacy of oral agar in management of indirect hyperbilirubinemia in full-term neonates. J Matern Fetal Neonatal Med 2022;35(5):975-980 (PMID 32192396), 2020-03-19. pubmed.ncbi.nlm.nih.gov
- Clegg ME, et al. The effect of agar jelly on energy expenditure, appetite, gastric emptying and glycaemic response. Eur J Nutr 2014;53(2):533-9 (PMID 23872837), 2013-07-20. pubmed.ncbi.nlm.nih.gov
- Sanaka M, et al. Effects of agar and pectin on gastric emptying and post-prandial glycaemic profiles in healthy human volunteers. Clin Exp Pharmacol Physiol 2007;34(11):1151-5 (PMID 17880369), 2007-11. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in marine and algae: Astaxanthin · Bladderwrack · Chlorella · Dunaliella · Ecklonia cava · Fucoidan · Kelp and seaweed · Sea moss · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.